In our study, inhibition of TBX5 was shown to dysregulate several genes such as DES, NKX2-5, ACTC1, MYH6, ATP2A2 and HSPB7, which further contributed to ICM-related diseases such as failure of heart and degeneration of heart (Figure 5). This evidence concerns the gene ACTC1 and heart failure.